Biotech pharma application for a large range of biologics

Amply™ Technology is currently applied to large range of cell lines and species including CHO cells, hybridoma, HEK293. This makes it really a powerful technology, as it is potentially applicable to a wide variety of expression systems.

 

AmplyCell consequently offers expertise and capabilities across the entire range of biologics, including antibodies, enzymes, cytokines, highly glycosylated proteins, fusion proteins, vaccines, peptides, conjugates, PEGylated proteins and others.

 

See our applications on :

Biosimilars

In-Vitro Diagnostics

DTEPs

NBEs